Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Appl Radiat Isot
TEPP-46 was dosed to mice orally at 50 mg/Kg twice per day
also known as BMS-512148
Retinoid differentiation therapy for common types of acute myeloid leukemia
CAL-101 - CAS# 870281-82-6 richlormethiazide Appl Radiat IsotIdelalisib, also known as CAL 101, is a PI3K delta inhibitor with potential immunomodulating and antineoplastic activities. CAL 101 inhibits the production of the second messenger phosphatidylinositol 3,4,5 trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and thus inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K delta is expressed primarily in hematopoietic lineages. The
US$ 138.26
US$ 273.18
US$ 188.90
US$ 126.47
US$ 188.90
US$ 394.19
US$ 141.26
US$ 105.49
US$ 357.35
US$ 285.79
US$ 197.09
US$ 264.00
US$ 188.90
US$ 370.75
US$ 485.10